Manipal Health Enterprises Limited · NSE:MANIPALHOS
Manipal Health Enterprises — Q1 FY27 Earnings Presentation
24 slides from Manipal Health Enterprises's earnings presentation, Aug 20, 2026
Slide 1: Exchange filing cover letter
Date: August 20, 2026 To, National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, C-1, Block G, 20th Floor, P.J. Towers, Bandra Kurla Complex, Bandra (E), Dalal Street, Mumbai – 400 051 Mumbai - 400001. NSE Scrip Symbol: MANIPALHOS BSE Scrip Code: 544847 Subject: Press Release and Inv
Slide 2: Manipal Hospitals Delivers 38.1% Revenue Growth and 26.4% EBITDA Growth in Q1 FY27
Manipal Hospitals Delivers 38.1% Revenue Growth and 26.4% EBITDA Growth in Q1 FY27 Patient-led growth and specialty care momentum support performance across the network Bengaluru, Karnataka, August 20, 2026: Manipal Health Enterprises Limited (Manipal Hospitals), India’s largest pan-India multi-spec
Slide 3: Performance Highlights
Performance Highlights: Particulars (₹ Cr) Q1 FY2027 Q1 FY2026* YoY Q4 FY2026 QoQ Revenue from 3,091 2,238 38.1% 2,882 7.2% Operations EBITDA 749 593(1) 26.4% 702 6.6% EBITDA Margin % 24.2% 26.5% (230) bps 24.4% (20) bps PAT 243(2) 254 (4.2)% 187 30.5% PAT Margin % 7.9% 11.4% (350) bps 6.5% 140 bps
Slide 4: About Manipal Hospitals
bed capacity, supported by a talented pool of 11,000+ doctors and an employee strength of over 25,000. With a commitment to provide patient-centric care, Manipal Hospitals combines clinical expertise with advanced technology, research and innovation to serve a multitude of patients across the globe.
Slide 5: Manipal Health Enterprises Limited: Q1 FY27
Manipal Health Enterprises Limited Earnings Update: Q1 FY27
Slide 6: Disclaimer
Disclaimer This presentation is issued by Manipal Health Enterprises Limited (the “Company”) for general information purposes only, without regards to the specific objectives, financial situation or requirements of any particular person. This presentation may not be copied, published, distributed or
Slide 7: Disclaimer
Disclaimer Actual results may be materially different from the expectations expressed or implied by this information, and there can be no assurance that the expectations reflected in this information will prove to be correct. By reading this presentation the recipient acknowledges that the recipient
Slide 8: Table of Contents
Table of Contents I Executive Summary II Performance Highlights III Other Updates IV Annexures 4
Slide 9: Senior Management Profile
Senior Management Profile Mr. Dilip Jose Mr. Sameer Agarwal Mr. Karthik Rajagopal MD & CEO Group CFO COO ▪ More than 36 years of experience including over 23 ▪ More than 28 years of experience in the field of Finance ▪ More than 19 years of experience in operational years of experience in healthcare
Slide 10: Manipal Hospitals at a Glance
Manipal Hospitals at a Glance Largest Pan-India Multispecialty Hospital Network Professionally Managed and Backed by by Bed Capacity 7 Marquee Investors DECADES OF TRACK RECORD Temasek Holdings Pvt Ltd (through indirect wholly owned subsidiaries) Rich Legacy of Founders TPG SG Magazine Pte. Ltd. 13,
Slide 11: Pan India Hospital Network
Pan India Hospital Network Key regions Network as of June 30, 2026 Karnataka (19 Hospitals | 6,404 Beds) Owned: 3,119; O&M: 3,285 Bed mix by West Bengal, Odisha, Jharkhand, and Sikkim (East India) Region (10 Hospitals | 2,887 Beds) Owned: 2,387; O&M:500 Maharashtra & Goa (13 Hospitals | Owned: 2,291
Slide 12: Q1FY27 Performance: Executive Summary
Q1FY27 Performance: Executive Summary EBITDA: INR 749 Cr PAT: INR 243 Cr Revenue: INR 3,091 Cr EBITDA Margin: 24.2% (+26.4%2 vs Q1FY26, (INR 332 Cr Ex-NCD int.4, (+38.1%1 vs Q1FY26) (Ex-Sahyadri: 25.0%) +29.7%3 w/o one off) +30.9% vs Q1FY26) Financial Metrics Occupancy: 65.0% ARPOB6: INR 71,500 / da
Slide 13: Performance Highlights
Performance Highlights India’s 1st Installation of Elekta Evo LINAC, an Online Adaptive radiotherapy for next-gen cancer treatment @ our recently launched North Bengaluru facility
Slide 14: Financial Highlights
Financial Highlights Revenue (INR Cr.) EBITDA (INR Cr.) and EBITDA Margin 26.5% 25.8% 24.4% 24.2% Growth: 38.1% 3,091 Growth: 29.7% 2,882 2,238 749 703 593 578 Q1FY26 Q4FY26 Q1FY27 Q1FY26 Q1FY26 Q4FY26 Q1FY27 (Ex-one off)1 PAT (INR Cr.) and PAT Margin Net Debt (INR Cr.) and Net Debt3 / EBITDA 11.4%
Slide 15: Operational Highlights
Operational Highlights # of Operational Beds Occupied beds & Occupancy % IP Volumes (in 000s) 62.1% 64.9% 65.0% Growth: 38.8% 4,584 4,657 7,064 7,164 155 146 5,430 3,374 112 Q1FY26 Q4FY26 Q1FY27 Q1FY26 Q4FY26 Q1FY27 Q1FY26 Q4FY26 Q1FY27 ARPOB (INR k/day) ALOS (Days) OP Volumes (in 000s) Growth: 8.7%
Slide 16: CONGO-R Specialties
CONGO-R Specialties Q1FY26 Q1FY27 15.5% 15.9% 10.8% 12.2% CONGO-R Mix : CONGO-R Mix : 64.7% 65.4% 9.1% 8.8% 7.5% 7.6% 7.4% 13.8% 7.1% 14.4% Centre of Excellence Cardiac Onco Neuro Gastro Ortho Renal Growth (y-o-y) 40% 62% 39% 35% 49% 41% Note: Congo-R Specialties Mix based on Gross Inpatient Revenue
Slide 17: Advanced Clinical Equipment Delivering Excellence at Scale
Advanced Clinical Equipment Delivering Excellence at Scale Advanced Medical Infrastructure that Enables Tertiary and Quaternary Care across Our Network1… Q1 FY27 Additions Tomotherapy Orthopedic & Spine 19 LINACs2 2 Units 25 Surgical Robots Soft Tissue Gamma 59 Cath Labs 44 MRI3 19 Robots 6 Cameras
Slide 18: Clinical Highlights
Clinical Highlights 1 MH Whitefield performs world’s first Robotic Pancreatic Surgery on a one-month-old infant for a case of Focal Congenital Hyperinsulinism MH Vijayawada successfully performed Andhra Pradesh's first emergency living donor liver transplant for acute liver failure 2 due to yellow p
Slide 19: Other Updates
Other Updates manipalhospitals LIFE’S ON
Slide 20: Region Wise Metrics
Region Wise Metrics Karnataka Region Maharashtra + Goa Region Particulars Q1FY26 Q1FY27 Particulars Q1FY26 Q1FY27 Revenue 1,115 1,373 Revenue 127 503 Operational Beds 2,028 2,294 Operational Beds 352 1,680 Occupancy % 60.9% 61.1% Occupancy % 54.8% 62.5% IP Volumes (‘000s) 43 51 IP Volume (‘000s) 7 3
Slide 21: Structured Plan for Sahyadri Integration
Structured Plan for Sahyadri Integration Revenue: INR 332 Cr Integration Vectors Update (+12.8% vs Q1FY261, +11.7% vs Q4FY26) Procurement Synergies • Centralized pricing rates rolled out Quantitative EBITDA: INR 58 Cr Efficiencies and Case Mix (+18.7% vs Q1FY261, • OP to IP conversion efficiencies a
Slide 22: Annexures
Annexures manipalhospitals LIFE’S ON
Slide 23: Income Statement
Income Statement Particulars (INR Cr.) Q1FY27 Q4FY26 Q1FY26 FY26 Revenue from operations 3,090.6 2,882.4 2,237.6 10,335.8 Less: Cost of materials consumed 626.1 587.7 456.6 2,116.2 Less: Employee benefits expense (excluding ESOP expenses) 449.6 379.9 328.1 1,457.1 Less: Other expenses 1,265.9 1,212.
Slide 24: Thank You
Thank You manipalhospitals LIFE’S ON
Manipal Health Enterprises — Q1 FY27 Earnings Presentation on 6ix